Skip to main content

Table 1 Schedule of enrollment, intervention, and assessment

From: Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial

  1. Abbreviations: 24 h UTP 24 h urinary total protein, UACR urinary albumin/creatinine ratio, eGFR estimated glomerular filtration rate, Scr serum creatinine, PT prothrombin time, APTT activated partial thromboplastin time, FIB fibrinogen ESRD end-stage renal disease, ALT alanine transaminase, AST aspartate aminotransferase, GGT gamma-glutamyl transpeptidase, TC total cholesterol, TGs triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TCM traditional Chinese medicine
  2. “×*” only for subjects that undergo losartan potassium unification (50 mg per day). “×#” only for subjects that take losartan potassium at 50 mg per day before enrollment